UBS raises Quest Diagnostics target price to $250 from $245
DGX•UBS raised its target price for Quest Diagnostics to $250 from $245.
Related News
U.S. stocks on the move: Centrus Energy, Disc Medicine, crypto
LEU•
China's central bank studies making overnight rate its main policy rate
FXI•
Alpha Tau wins FDA approval to expand recurrent glioblastoma trial to 20 patients
DRTS•
Itron study finds 93% of utilities expand data investments beyond original uses
ITRI•
Globaltek Ventures engages Bansal to review first-half 2026 financial statements
ATVK•